Quick Answer
20/20 Biolabs, Inc. reported Stockholders Equity of -$19.2 thousand for fiscal year 2025.
20/20 Biolabs, Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | -$19.2K | -101.3% |
| 2024 | $1.51M | -64.9% |
| 2023 | $4.29M | — |
- 20/20 Biolabs, Inc. showed a decrease of -101.3% in Stockholders Equity compared to the prior fiscal year.
- Over the 2023–2025 period, 20/20 Biolabs, Inc.’s stockholders equity has declined by 100.4% (from $4.29 million to -$19.2 thousand).
- The most recent figure is from 20/20 Biolabs, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: